Mathew Blackman
Stock Analyst at Stifel
(1.77)
# 1237
Out of 5,273 analysts
63
Total ratings
53.33%
Success rate
16.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Beta Bionics | Initiates Coverage On: Buy | 25 | 18.49 | 35.21% | 1 | Feb 24, 2025 | |
Insulet | Maintains: Hold | 245 293 | 269.08 | 8.89% | 3 | Feb 21, 2025 | |
Globus Medical | Maintains: Strong Buy | 92 94 | 78.16 | 20.27% | 5 | Feb 21, 2025 | |
Orthofix Medical | Upgrades: Buy | 18 24 | 17.02 | 41.01% | 5 | Nov 8, 2024 | |
Cerus | Maintains: Buy | 6 3 | 1.58 | 89.87% | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 238 | 283.78 | -16.13% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 50 | n/a | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 90 100 | 82.41 | 21.34% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 16 | 11.8 | 35.59% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 55 60 | 19.5 | 207.69% | 5 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 6 7 | 8.05 | -13.04% | 11 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 8 9 | 13.46 | -33.14% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 18 11 | 10.35 | 6.28% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 | n/a | n/a | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 16 | n/a | n/a | 2 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 64 | n/a | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 | n/a | n/a | 2 | Aug 26, 2020 |